Showing results (91-100 of 151) with videos related to
Sort By:
Pageof 16
Cardiovascular Drug Reviews|December 15, 2007
Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefitsRuitang DengCardiovascular Drug Reviews|October 20, 2004
Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damageHideaki Hara, Nobuko Toriu, Masamitsu ShimazawaCardiovascular Drug Reviews|June 5, 2004
Ramatroban (BAY u 3405): a novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptorToshiaki Ishizuka, Takemi Matsui, Yasuhiro Okamoto, et al.Cardiovascular Drug Reviews|June 5, 2004
Pharmacological effects of xanthones as cardiovascular protective agentsDe-Jian Jiang, Zhong Dai, Yuan-Jian LiCardiovascular Drug Reviews|December 14, 2004
CandesartanChristoph H Gleiter, Chrstine Jägle, Ursula Gresser, et al.Cardiovascular Drug Reviews|October 28, 2005
Role of mitogen-activated protein (MAP) kinases in cardiovascular diseasesNilesh Pandya, Dev Santani, Sunita JainCardiovascular Drug Reviews|October 28, 2005
Gö 6983: a fast acting protein kinase C inhibitor that attenuates myocardial ischemia/reperfusion injuryLindon H Young, Brian J Balin, Margaret T WeisCardiovascular Drug Reviews|October 9, 2007
Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypassAndrew W Hoel, Michael S ConteCardiovascular Drug Reviews|January 12, 2007
L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrugDavid S GoldsteinCardiovascular Drug Reviews|January 12, 2007
Sulodexide: a renewed interest in this glycosaminoglycanD Adam Lauver, Benedict R LucchesiPageof 16